𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A comparison of survival, with and in the absence of, liver transplantation in the absence of a non-transplant cohort: the case of alcoholic cirrhosis

✍ Scribed by T.A. Young; J. Neuberger; L. Longworth; J. Ratcliffe; M.J. Buxton

Book ID
119526974
Publisher
Elsevier Science
Year
2001
Tongue
English
Weight
149 KB
Volume
34
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cirrhosis after orthotopic liver transpl
Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence
✍ Moataz Seyam; James M. Neuberger; Bridget K. Gunson; Stefan G. HΓΌbscher πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

Liver allograft cirrhosis is a relatively uncommon complication of liver transplantation. Most cases can be attributed to disease recurrence, particularly recurrent hepatitis C. Little is known about the frequency, etiology, and natural history of liver allograft cirrhosis occurring without evidence

Hepatocellular carcinoma after renal tra
Hepatocellular carcinoma after renal transplantation in the absence of cirrhosis or viral hepatitis: A case series
✍ Saeian, Kia ;Franco, JosΓ© ;Komorowski, Richard A. ;Adams, Mark B. πŸ“‚ Article πŸ“… 1999 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 171 KB

The occurrence of hepatocellular carcinoma (HCC) in renal transplant recipients has typically been associated with hepatitis B or C infection. We encountered two cases of HCC in renal transplant recipients with negative hepatitis B and C markers and no underlying liver pathology, in whom immunosuppr

Non-alcoholic fatty liver disease progre
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
✍ Judith Ertle; Alexander DechΓͺne; Jan-Peter Sowa; Volker Penndorf; Kerstin Herzer πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 402 KB

## Abstract Non‐alcoholic fatty liver disease (NAFLD) is the most common liver disease in developed countries, and accumulating evidence suggests it as the hepatic manifestation of the metabolic syndrome (MS). Although the published prevalence of hepatocellular carcinoma (HCC) is low in NAFLD/NASH